Squamous cell carcinoma of an unknown primary tumor located in the cervical lymph nodes

Carcinoma of an Unknown Primary Site

Volumn , Issue , 2006, Pages 117-126

  Kaminsky, Marie Christine ^a   Blot, Emmanuel ^b  

^a CENTRE ALEXIS VAUTRIN   (France)

^b CENTRE HENRI BECQUEREL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82555199331     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30:153-164.
2. Million RR, Cassisi NJ, Manguso AA. The unknown primary. In: Management of Head and Neck Cancer: A Multidisciplinary Approach. 2d ed. Philadelphia: JB Lippincott, 1999:311-320.
3. Strojan P, Anicin A. Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumor. Radiother Onkol 1998; 49:33-40.
4. Oen AL, De Boer MF, Hop WC, Knecht P. Cervical metastasis from unknown primary tumor. Eur Arch Otolaryngol 1995; 252:222-228.
5. Lapeyre M, Malissard L, Peiffert D, Hoffstetter S, Toussaint B, Renier S. Cervical lymph node metastasis from an unknown primary: is a tonsillectomy necessary? Int J Radiat Oncol Biol Phys 1997; 39:292-296.
6. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Casisi NJ. Diagnosis evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20:2739-2744.
7. Berker JL, Zhen WK, Hoffmann HT, McCuloch TM, Buatti JM. Squamous cell carcinoma metastatic to cervical lymph nodes from unknown primary: a changing disease. Int J Radiat Oncol Biol Phys 2000; 48:320.
8. Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Aug KK. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck 1998; 20:674-681.
9. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55:121-129.
10. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50:55-63.
11. Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG. The occult head and neck primary: to treat or not to treat? Clin Oncol 1997; 9:322-329.
12. Barbara A, Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treatment Rev 2004; 30:153-164.
13. Fitzpatrick PJ, Kotalik JF. Cervical metastases from an unknown primary tumor. Radiology 1974; 110:659-663.
14. Mancuso AA, Maceri D, Rice D, Hanafee W. CT of cervical lymph node cancer. Am J Roentgenol 1981; 136:381-385.
15. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology 1984; 152:749-753.
16. Jesse R, Perez C, Fletcher G. Cervical lymph node metastasis: unknown primary cancer. Cancer 1973; 31:854-859.
17. De Braud F, Al Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 1993; 20:273-278.
18. Califano J, Westra WH, Koch W, et al. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 1999; 7:599-604.
19. Gabalski EC, Belles W. Management of the unknown primary in patients with metastatic cancer of the head and neck. Ear Nose Throat J 2000; 79:306-308.
20. Becuwe B, Volant A, Danie C, Leroy JP. Interêt de l'amygdalectomie dans le bilan etiologique d'une adenopathie cervicale metastatique d'aspect kystique, et en apparence primitive. Les cahiers d'ORL 1982; 17:151-157.
21. Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124:331-333.
22. Randall DA, Johnstone PA, Foss RD, Martin PJ. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000; 122:52-55.
23. Robbins KT, Cole R, Marvel J, Fields R, Wolf P, Goepert H. The violated neck: cervical node biopsy prior to definitive treatment. Otolaryngol Head Neck Surg 1986; 94:605-610.
24. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imag 2003; 30:411-416.
25. Bohuslavizki KH, Klutmann S, Sonnemann U, et al. F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region [article in German]. Laryngorhinootologie 1999; 78:445-449.
26. Greven KM, Keyes JW Jr, Williams DW III, McGuirt WF, Joyce WT III. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-d-glucose. Cancer 1999; 86:114-118.
27. Assar OS, Fischbein NJ, Caputo GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999; 210:177-181.
28. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT. Radiology 1996; 199:761-766.
29. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003; 15: 461-466.
30. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implication of 18F-fluoro-2-deoxy-d-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002; 112:2009-2014.
31. Jungehulsing M, Scheidhauer K, Damm M, et al. 2[F]-fluoro-2-deoxy-d-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123: 294-301.
32. Perie S, Talbot JN, Monceaux G, et al. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin. Ann Otol Rhinol Laryngol 2000; 109: 755-760.
33. Nieder C, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol 2002; 3:33-40.
34. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnosic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990-2005.
35. Tong CC, Luk MY, Chow SM, Ngan KC, Lau WH. Cervical nodal metastases from occult primary: undifferentiated carcinoma versus squamous cell carcinoma. Head Neck 2002; 24:361-369.
36. Iganej S, Kagan R, Anderson P, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002; 24:236-246.
37. Mendenhall WM, Mancuso AA, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site. Am J Otolaryngol 2001; 22:261-267.
38. Werner JA, Dunne AA. Value of neck dissection in patients with squamous cell carcinoma of unknown primary. Onkologie 2001; 24:16-20.
39. Fernandez JA, Suarez C, Martinez JA, Llorente JL, Rodrigo JP, Alvarez JC. Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors. Clin Otolaryngol 1998; 23:158-163.
40. Medini E, Medini AM, Lee CK, Gapany M, Levitt SH. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol 1998; 21:121-125.
41. Maulard C, Housset M, Brunel P, et al. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope 1992; 102:884-890.
42. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992; 23:743-749.
43. Yalin Y, Pingzhang T, Smith GI, Ilankovan V. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study. Br J Oral Maxillofac Surg 2002; 40:484-487.
44. Issing WJ, Taleban B, Tauber S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003; 260:436-443.
45. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP. Cervical metastases ofoccult origin: the impact of combined modality therapy. Am J Surg 1994; 168:395-399.
46. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 1997; 37:797-802.
47. Jeremic B, Zivic L, Jevremovic S. Radiotherapy and cisplatin in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck. A phase II study. J Chemother 1992; 4:399-402.
48. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiother-apy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21:92-98.
49. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081-2086.
50. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregio-nal treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355:949-955.
51. Bernier J, Domenge C, Ozsahin M, et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350:1945-1952.
52. Cooper JS, Pajak TF, Forastiere AA, et al. Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350:1937-1944.
53. Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 2004; 22:1743-1752.
54. Lefebvre JL, Coche-Dequeant B, Ton Van J, Buisset E, Adenis A. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990; 160:443-446.
55. Maulard C, Housset M, Brunel P, et al. Primary cervical lymph nodes of epidermoid type. Results of a series of 123 patients treated by the association surgery-radiotherapy or irradiation alone. Ann Otolaryngol Chir Cervicofac 1992; 109:6-13.
56. Spiro RH, Derose G, Strong EW. Cervical node metastasis of occult origin. Am J Surg 1983; 146:441-446.
57. Wang RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990; 116:1388-1393.
58. Gehanno P, Veber F, Blanchet F. Metastatic cervical adenopathies appearing as primary. A propos of 124 cases. Acta Chir Belg 1983; 83:142-150.
59. Jose B, Bosch A, Caldwell WL, Frias Z. Metastasis to neck from unknown primary tumor. Acta Radiol Oncol Radiat Phys Biol 1979; 18:161-170.